A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 94, Issue 1, 2010, Pages 157-164

  Lindfors, Nina C ^a   Koski, Ilona ^b   Heikkilä, Jouni T ^b   Mattila, Kimmo ^b   Aho, Allan J ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bioactive glass; Biocompatibility hard tissue; Bone substitute

Indexed keywords

AUTOGENOUS BONE; BIOCOMPATIBILITY/HARD TISSUE; BONE GRAFT SUBSTITUTES; BONE SUBSTITUTE; BONE SUBSTITUTES; BONE TUMOR; CT SCAN; FATTY BONES; FOLLOW-UP STUDIES; LONG-TERM FOLLOW-UP STUDY; MRI SCAN;

BONE; COMPUTERIZED TOMOGRAPHY; TUMORS;

BIOACTIVE GLASS;

ARTICLE; BENIGN TUMOR; BIOCOMPATIBILITY; BONE DENSITY; BONE GRAFT; BONE MARROW; BONE PROSTHESIS; BONE TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; ENCHONDROMA; FEMALE; FIBROMA; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY;

BIOCOMPATIBLE MATERIALS; BONE NEOPLASMS; BONE SUBSTITUTES; BONE TRANSPLANTATION; CHILD; FEMALE; FOLLOW-UP STUDIES; GLASS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 77954131434     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31636     Document Type: Article

References (21)

1. Hench LL. Bioceramics: From concept to clinics. J Am Ceram Soc 1991;74:1487-1510.
2. Gatti AM, Yamamuro T, Hench LL, Andersson ÖH. In-vivo reactions in some bioactive glasses and glass-ceramic granules. Cells Mater 1993;3:290-296.
3. Heikkilä JT, Aho HJ, Yli-Urpo A, Happonen RP, Aho AJ. Bone formation in rabbit cancellous bone defects filled with bioactive glass granules. Acta Orthop Scand 1995;66:463-467.
4. Lindfors NC, Aho AJ. Granule size and composition of bioactive glass affect osteoconduction in rabbit. J Mat Sci:Mat Med 2003;14:265-372.
5. Dieudonne SC, Dolder van der J, Ruiter de JE, Paldan H, Peltola T, Hof van't MA, Happonen RP, Jansoen JA. Osteoblast differentiation of bone marrow stromal cells cultured on silica gel and so-derived titania. Biomaterials 2002;23:3041-3051.
6. Virolainen P, Heikkilä J, Yli-Urpo A, Vuorio E, Aro HT. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone healing. J Biomed Mater Res 1997;35:9-17. (Pubitemid 27143007)
7. Välimäki V-V, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg 2006;95:95-102.
8. Hench LL. Bioactive ceramics. Ann N Y Acad Sci 1988;523:54-71.
9. Andersson ÖH, Karlsson KH, Kangasniemi K. Calcium phosphate formation at the surface of 8ioactive glass in vivo. J Non-Cryst Solids 1990;119:290-296. (Pubitemid 20720968)
10. Andersson Ö, Karlsson KH. On the bioactivity of silicate glass. J Non-Cryst Solids 1991;129:145-151.
11. Hench LL, Paschall HA. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res Symp 1973;4:25-42.
12. Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, Ylänen H, Salonen JI, Viljanen MK, Eerola E. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci: Mater Med 2008;19:547-551. (Pubitemid 351236756)
13. Munukka E, Leppäranta O, Korkeamäki M, Vaahto M, Peltola T, Zhang D, Hupa L, Ylänen H, Salonen JI, Viljanen MK, Eerola E. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci: Mater Med 2008;19:27-32.
14. Lindfors NC, Heikkilä JT, Koski I, Mattila K, Aho HJ. Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res B: Appl Mater 2009;90:131-136.
15. Day RM. Bioactive glass stimulates the secretion of angiogenetic growth factors and angiogenesis in vitro. Tissue Eng 2005;11:768-777.
16. Greenspan A, Remagen W. Differential Diagnosis of Tumors and Tumor-Like Lesions of Bones and Joints. PA, USA: Lippincot-Raven Publishers; 1998. p 8.
17. Wilson T, Parikka V, Holmbom J, Ylänen H, Penttinen R. Intact surface of bioactive glass S53P4 is resistant to osteoclastic activity. J Biomed Mater Res 2006;77A; 67-74.
18. Lindfors NC. Treatment of a recurrent aneurysmal bone cyst with bioactive glass in a child allows for good remodellation and growth. Bone 2009;45:398-400.
19. Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR. Bone defects following curettage do not necessary need augmentation. Acta Orthop 2009;80:4-8.
20. Yanagawa T, Watanabe H, Shinozaki T, Takagishi K. Curettage of benign bone tumors without grafts gives sufficient bone strength. Acta Othop 2009;80:9-13.
21. Athanasian EA. Aneurysmal bone cyst and giant cell tumor of bone of the hand and distal radius. Hand Clinics 2004;20:269-281.